INSIGHT-Unease grows among U.S. doctors over Indian drug quality

WASHINGTON/NEW YORK, March 18 (Reuters) - Some U.S. doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.